semaglutide studies 2024 GLP-1 Agonists Weight Loss Drugs Market Report, 2025-2030 The multifaceted effects of semaglutide:

Importantly, these increases did not correlate with serious adverse cardiovascular events in the trial populations, and heart rate typically returned toward baseline levels as treatment continued beyond the dose-escalation phase

In the same analysis of SURE, the reduction in body weight among Swedish participants ( n = 193) was 5.7 kg, as compared to 4.6 kg in the present study [26]

Semaglutide itself does not directly cause vaginal dryness, but the rapid fat loss it produces can reduce estrogen levels because adipose tissue produces estrogen through aromatization

By combining advanced medical science with a compassionate, human-centered approach, we make sustainable weight loss not just a goal, but an attainable reality

In one trial , participants lost about 2% of their body weight after the first month of taking semaglutide